Building the Future of Medical Cannabis in France
PGP FARMER is positioning itself as a future leader in the French medical cannabis industry. As regulations evolve, we are preparing to offer high-quality, GMP and GACP-certified products tailored to the needs of the pharmaceutical sector. With over 25 years of expertise in large-scale cannabis production, we combine innovation and compliance to meet the growing demand for standardized medical cannabis solutions.
A Strong Market Opportunity
The medical cannabis industry is expanding rapidly, with increasing demand from laboratories and medical institutions. With a solid foundation in research, genetics, and pharmaceutical-grade production, PGP FARMER is committed to providing high-quality solutions that align with international standards.
Collaborating for Excellence
We work closely with pharmaceutical companies, research institutions, and healthcare providers to develop tailored solutions that meet industry needs. Our expertise in genetics, cultivation, and extraction ensures reliable and scalable production.
Join the Movement
Discover our approach, market projections, and opportunities for collaboration. Contact our team to learn more about how PGP FARMER is shaping the future of medical cannabis.
Partnerships & Investors
The medical cannabis market in Europe is booming. By 2030, the demand for raw materials could reach 700 tons, including 150 tons for France, i.e. 20% of the European market.1% of the European population could be concerned by prescriptions for therapeutic cannabis-based medicines.
